This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Power of Diagnostic Imaging in Early Disease Detection Medical imaging is one of the most significant developments in medical science. By allowing doctors to view the inside of the body without the need for surgery, this technology aids in the early detection of diseases. How Does Early Detection Help?
The fragmented nature of medical image storage and access makes it much harder for healthcare providers to access patient data and lowers the probability of positive healthcare outcomes. As healthcare imaging technologies advance, it’s likely that healthcare centers will produce a rising volume of images.
GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. The company received approval from the U.S. Food and Drug Administration (FDA) for the injection in 2024.Flyrcadois
However, mpMRI misses about 10% of cases, typically in patients with lower-grade disease and in patients with cribriform pattern disease, a subtype much more likely to recur after surgery or radiation therapy, he noted. It also includes a well-established grading system that accurately correlates with histopathology.
and radiology has learned much since then, according to experts who directly dealt with the diseases impact. This was something that healthcare systems in the U.S. in the modern era of healthcare had not been used to adapting to, as was the general public, said Ella Kazerooni, MD, from the University of Michigan.
Advances in patient monitoring, such as wearable devices, remote monitoring systems, and AI-powered analytics, are shifting the possibilities of modern healthcare. The ability to monitor patients remotely is significantly impacting healthcare delivery, resulting in reduced costs and more positive patient outcomes.
Ultrahigh-spatial-resolution photon-counting detector CT (PCCT) improves the evaluation of coronary artery disease (CAD) -- enabling the reclassification of disease to a lower category in 54% of patients, researchers have found. Curved multiplanar reconstructions with 0.6-mm mm (yellow outline), 0.4-mm mm (blue outline), and 0.2-mm
VIENNA – GE HealthCare (GEHC) is highlighting a revamped ultrasound product line, the European launch of its Signa Champion 1.5-tesla In addition, the scalable scanner supports a wide variety of transducers, including GEHC’s XDclear offerings and wireless Vscan Air CL probe GE HealthCare's new Totus ultrasound scanner.
Healthcare disparities continue to plague medical imaging, but there are concrete measures radiologists can take to mitigate them, according to a paper published on October 12 in RadioGraphics. Histopathologic biopsy results demonstrated invasive mammary carcinoma with metastatic disease in a right axillary lymph node.
ALZ-NET is a voluntary healthcare provider-enrolled network collecting real-world clinical and imaging data from people evaluated for or treated with new Alzheimers disease treatments.
Healthcare practitioners can use this data to evaluate patients with neurodegenerative disorders such as Alzheimer's disease. healthcare facilities and is intended for use by neurologists, radiologists, and other trained healthcare practitioners familiar with the post-processing of MR images.
The Care Innovation Hub leverages the strengths of academia and industry to create, evaluate and translate novel technology into a clinical setting with the goals of advancing diagnosis and treatment of disease, improving hospital operations and driving more equitable access to care. tim.hodson Mon, 01/27/2025 - 10:11 Jan.
GE HealthCare has received U.S. Food and Drug Administration (FDA) approval for its flurpiridaz F-18 radiotracer for PET imaging of coronary artery disease. The radiotracer has a half-life of 109 minutes, which is significantly longer than existing PET MPI tracers, GE HealthCare added. with 695,000 deaths recorded in 20214.
GE HealthCare plans to launch its Flyrcado (flurpiridaz F-18) injection in the U.S. Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. The company received approval from the U.S. Food and Drug Administration (FDA) for the injection in 2024.Flyrcadois
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. GE HealthCare's new Revolution Ascend CT scanner. GE HealthCare's Signa Champion 1.5-tesla MRI GEHC unveiled Signa Champion, a 1.5-tesla, tesla scanner.
The University of California, San Francisco (UCSF) and GE HealthCare (GEHC) have launched a joint research hub focused on neurodegenerative disease and cancer. The Care Innovation Hub builds on a decades-long history between UCSF and GE HealthCare and brings these research focus areas under one framework, UCSF noted.
Continuing to expand its ultrasound AI capabilities, GE HealthCare has signed an agreement to acquire Wales-based Intelligent Ultrasound Group's clinical AI software business for total consideration of approximately $51 million. Intelligent Ultrasound Chief Operating Officer Nick Sleep will also come over to GE HealthCare.
As a result, healthcare expenditures will rise, and the industry’s workforce will see a surge in demand across many roles connected to aging populations. Here is what to expect in the coming years as the baby boomers age for someone interested in healthcare workforce trends. healthcare system is at a crossroads.
What does the future of heart disease detection look like? He also discusses how this innovative solution is not just advancing diagnostic precision but also reshaping the way healthcare providers approach heart disease treatment and patient care.
The American Liver Foundation (ALF) is introducing its new Project Echo program for healthcare providers that aims to bring treatment and prevention best practices for nonalcoholic fatty liver disease (NAFLD) to nonliver experts.
has released QureOS, a digital health operating system for improving health access among underserved populations and guiding the adoption of healthcare technology. It also features an AI chatbot to aid clinical decision support for primary healthcare, the company said.
more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,
Centers for Disease Control and Prevention (CDC) acknowledges that “health disparities are preventable differences in the burden of disease, injury, violence, or opportunities.” Hospitals committed to addressing the root causes of healthcare disparities can start by addressing some of the following opportunities.
Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia. from Ukraine.
GE HealthCare (GEHC) and Medis Medical Imaging will collaborate on developing and commercializing software for diagnosing and treating coronary artery disease (CAD). The software will be added to GE HealthCare’s interventional cardiology portfolio surrounding the Allia platform, GE HealthCare added.
28, 2025 GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of VolusonExpert Series ultrasound systems. Centers for Disease Control and Prevention; 2020. tim.hodson Wed, 01/29/2025 - 12:02 Jan. Accessed January 17, 2025.
However, it's also a moment to acknowledge the persistent disparities that continue to affect Black communities, particularly in healthcare. These disparities are not merely statistical outliers but indicative of systemic issues within our healthcare system. and a time to reflect on our progress toward equality and justice.
GE HealthCare is collaborating with Novo Nordisk to further advance the clinical and product development of peripheral-focused ultrasound (PFUS) to treat type 2 diabetes and obesity. Previous reports suggest that it could impact glucose metabolism in people with diabetes through personalized ultrasound stimulation of nerve pathways.
GE HealthCare (GEHC) has installed its first Allia IGS Pulse image-guided system for the diagnosis and treatment of cardiovascular diseases in interventional cardiology.
Offering higher diagnostic efficacy than SPECT imaging for coronary artery disease (CAD) detection, the PET myocardial perfusion imaging agent Flyrcado™ (flurpiridaz F 18, GE HealthCare) provides unit dose availability and effectiveness in imaging patients with high BMI.
GE HealthCare (GEHC) and the University of Wisconsin-Madison have inked a 10-year strategic research collaboration that expands the existing scope of their relationship. GE HealthCare has had a long-standing relationship with UW-Madison, providing research support, funding, diagnostic imaging equipment, and research staff.
Near-miss MRI incident in California prompts oversight questions A "freak accident" at a California healthcare facility in April highlighted a lack of standard reporting mechanisms and oversight in MRI safety incidents, this AuntMinnie brief noted.
“AI-based image analysis provides a promising approach for noninvasive assessment of liver fibrosis on ultrasound images, offering an accessible tool for primary healthcare setting,” Chen and colleagues wrote. Noninvasive tests can be used to screen patients with chronic liver disease for advanced liver fibrosis.
millions in healthcare costs, according to a study published May 14 in PLOS One. The radiotracer was developed by French biomarker firm Zionexa, which GE HealthCare acquired in May 2021. F-18 FES-PET was approved in May 2020 for detecting ER-positive lesions in patients with recurrent or metastatic breast cancer.
Researchers from Zurich have developed a cumulative clinical risk (CCR) score that may provide an early predictive marker for long-term brain alterations and cognitive impairments in patients with congenital heart disease (CHD). Figure courtesy of Melanie Ehrler, PhD, et al.
Fujifilm Healthcare Americas has entered into a partnership with Us2.ai ai's software automates the analysis and reporting of echocardiograms and provides cardiac measurements for the diagnosis of heart disease. ai to equip Fujifilm's Lisendo 800 cardiovascular ultrasound system with Us2.ai's ai's AI-driven echocardiography software.
Far from being expendable, human medical experts will remain the linchpin of our healthcare system and the indispensable source of truth whose inputs allow AI models to learn as they go in ways that improve patient health. Roland Rott of GE HealthCare. Roland Rott is chief imaging officer at GE HealthCare.
The 2025 Medicare reimbursement updates bring significant changes for healthcare providers, particularly in coronary computed tomography angiography (CCTA) and other imaging services. Healthcare providers must navigate these reimbursement shifts carefully to maintain financial stability while continuing to offer high-quality imaging services.
A large study, needed for FDA clearance, demonstrated that the use of icobrain aria significantly increases the accuracy of ARIA assessments by radiologists and hence allows for safer use of new amyloid-beta targeting therapies for Alzheimer’s disease patients.
Our mission is not just to offer diagnostic insights but to ensure every patient feels supported and cared for throughout their healthcare journey. Calcium in the coronary arteries is often a sign of atherosclerosis or plaque buildup, which can increase the risk of heart disease and heart attacks.
mtaschetta-millane Fri, 07/26/2024 - 12:30 July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. GE HealthCare has selected AWS as its strategic cloud provider and plans to use its healthcare and generative AI services to build and implement new, versatile foundation models to transform the future of healthcare.
Lymphedema is a chronic disease of the lymphatic system caused by the accumulation of proteins in the interstitium, ultimately leading to inflammation, and can be caused by damage to the lymphatic system from surgery or radiation treatment, the authors explained. The disease is a particular concern among cancer patients, they noted.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content